# Short-term Clinical Feasibility of the New Provox Vega 22.5 Voice Prosthesis

> **NCT00743262** · PHASE1,PHASE2 · COMPLETED · sponsor: **Atos Medical AB** · enrollment: 15 (actual)

## Conditions studied

- Total Laryngectomy

## Interventions

- **DEVICE:** Provox voice prosthesis

## Key facts

- **NCT ID:** NCT00743262
- **Lead sponsor:** Atos Medical AB
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2008-08
- **Final completion:** 2009-04
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2023-07-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00743262

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00743262, "Short-term Clinical Feasibility of the New Provox Vega 22.5 Voice Prosthesis". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT00743262. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*